The peripheral blood of cancer patients, particularly those with a high disease burden, is enriched for CD8+ T cells expressing checkpoint proteins indicating exhaustion and immunotherapy resistance, including PD-1, TIM3, TIGIT, and LAG3 (3–7). This evidence concerns the gene CD8A and cancer.